Day, John W.
Howell, Kelly
Place, Amy
Long, Kimberly
Rossello, Jose
Kertesz, Nathalie https://orcid.org/0000-0001-6955-5934
Nomikos, George
Article History
Received: 12 December 2021
Accepted: 16 October 2022
First Online: 3 November 2022
Declarations
:
: Not applicable.
: Not applicable.
: Drs. George Nomikos, Nathalie Kertesz and Jose Rossello are employees of Scholar Rock, Inc. and are shareholders. Drs. Amy Place and Kimberly Long are former employees of Scholar Rock. Dr. John Day reports grants from: AMO Pharma; Audentes; Avidity; Biogen; Cytokinetics; Genentech; Ionis Pharmaceuticals; Novartis Gene Therapies; Roche Pharmaceuticals; Sanofi-Genzyme; Sarepta Therapeutics; Scholar Rock, and has received support from participating on advisory boards or having consulted with: Affinia Therapeutics; AMO Pharmaceuticals; Avidity Biosciences; Biogen; Cytokinetics; Epirium Bio; Ionis Pharmaceuticals; Kate Therapeutics; Novartis Gene Therapies; Roche/Genentech Pharmaceuticals; Sarepta Therapeutics; Scholar Rock; Shift Therapeutics; and Vertex Pharmaceuticals. Dr Kelly Howell has nothing to disclose.